Journal of Current Glaucoma Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  18 (2024)
Volume  17 (2023)
Volume  16 (2022)
Volume  15 (2021)
Volume  14 (2020)
Volume  13 (2019)
Volume  12 (2018)
Volume  11 (2017)
Volume  10 (2016)
Volume  9 (2015)
Volume  8 (2014)
Volume  7 (2013)
Volume  6 (2012)
Related articles

VOLUME 18 , ISSUE 2 ( April-June, 2024 ) > List of Articles

REVIEW ARTICLE

A Review of Canaloplasty in the Treatment and Management of Glaucoma

Isabella V Wagner, Caleb Towne, Marie C Saade, P Connor Lentz, Arianna Rashedi, Pranav Vasu, Nithya Boopathiraj, Leticia Checo, Chelsey Krambeer, Darby D Miller, Syril Dorairaj

Keywords : Canaloplasty, Glaucoma, Glaucoma surgery, iTrack, OMNI surgical system

Citation Information : Wagner IV, Towne C, Saade MC, Lentz PC, Rashedi A, Vasu P, Boopathiraj N, Checo L, Krambeer C, Miller DD, Dorairaj S. A Review of Canaloplasty in the Treatment and Management of Glaucoma. J Curr Glaucoma Pract 2024; 18 (2):79-85.

DOI: 10.5005/jp-journals-10078-1442

License: CC BY-NC 4.0

Published Online: 10-07-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Aim: To review the published literature evaluating the safety and efficacy outcomes of canaloplasty performed in the treatment of glaucoma. Background: Canaloplasty is a nonpenetrating glaucoma procedure involving combined 360° circumnavigation and viscodilation of Schlemm's canal. The procedure may be performed under an ab externo (with tensioning suture) or ab-interno (conjunctiva-sparing) approach. Given the wide variety of glaucoma procedure types and approaches, further investigation into the role of canaloplasty in ophthalmological practice is warranted. The objectives of this narrative review are to synthesize the existing literature in order to investigate indications, safety and efficacy outcomes, and the optimal place of canaloplasty in glaucoma treatment and management. Review of results: A total of 60 articles were included in this review. Both ab externo and ab-interno canaloplasty (ABiC) were found to be significantly effective at reducing intraocular pressure (IOP) and glaucoma medication burdens in patients with mild-to-moderate open-angle glaucoma (OAG). These findings remained consistent regardless of phacoemulsification status. ABiC was found to exhibit a safety profile favorable compared to trabeculectomy and comparable to minimally invasive trabecular bypass implants. Conclusion: Canaloplasty is a nonpenetrating surgical intervention that is highly effective in treating patients with mild-to-moderate OAG across a large variety of clinical scenarios. Clinical significance: These findings support the clinical use of canaloplasty in ophthalmological practice, clarify its patient profile, and compare procedural outcomes to other minimally invasive glaucoma surgery (MIGS) devices on the market.

HTML PDF Share
  1. Brusini P. Canaloplasty in open-angle glaucoma surgery: a four-year follow-up. Sci World J 2014;2014:469609. DOI: 10.1155/2014/469609
  2. Harvey BJ, Khaimi MA. A review of canaloplasty. Saudi J Ophthalmol 2011;25(4):329–336. DOI: 10.1016/j.sjopt.2011.08.003
  3. Bull H, von Wolff K, Körber N, et al. Three-year canaloplasty outcomes for the treatment of open-angle glaucoma: European study results. Graefes Arch Clin Exp Ophthalmol 2011;249(10):1537–1545. DOI: 10.1007/s00417-011-1728-3
  4. Grieshaber MC, Fraenkl S, Schoetzau A, et al. Circumferential viscocanalostomy and suture canal distension (canaloplasty) for whites with open-angle glaucoma. J Glaucoma 2011;20(5):298–302. DOI: 10.1097/IJG.0b013e3181e3d46e
  5. Liu H, Zhang H, Li Y, et al. Safety and efficacy of canaloplasty versus trabeculectomy in treatment of glaucoma. Oncotarget 2017;8(27):44811–44818. DOI: 10.18632/oncotarget.14757
  6. Gedde SJ, Herndon LW, Brandt JD, et al. Postoperative complications in the tube versus trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol 2012;153(5):804.e1–814.e1. DOI: 10.1016/j.ajo.2011.10.024
  7. Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg 1999;25(3):316–322. DOI: 10.1016/s0886-3350(99)80078-9
  8. Wagdy FM. Canaloplasty versus viscocanalostomy in primary open angle glaucoma. Electron Physician 2017;9(1):3665–3671. DOI: 10.19082/3665
  9. Konopińska J, Mariak Z, Rękas M. Improvement of the safety profile of canaloplasty and phacocanaloplasty: a review of complications and their management. J Ophthalmol 2020;2020:8352827. DOI: 10.1155/2020/8352827
  10. Byszewska A, Konopińska J, Kicińska AK, et al. Canaloplasty in the treatment of primary open-angle glaucoma: patient selection and perspectives. Clin Ophthalmol 2019;13:2617–2629. DOI: 10.2147/OPTH.S155057
  11. Xie MS, Zheng YZ, Huang LB, et al. Experimental circumferential canaloplasty with a new Schlemm canal microcatheter. Int J Ophthalmol 2018;11(1):1–5. DOI: 10.18240/ijo.2018.01.01
  12. Smit BA, Johnstone MA. Effects of viscoelastic injection into Schlemm's canal in primate and human eyes: potential relevance to viscocanalostomy. Ophthalmology 2002;109(4):786–792. DOI: 10.1016/s0161-6420(01)01006-5
  13. Iscience Interventional Ophthalmic Microcatheter 510(k) FDA Premarket Notification K080067 ISCIENCE INTERVENTIONAL [Internet]. [cited 2022 Aug 18]. Available from: https://fda.report/PMN/K080067
  14. Klink T, Sauer J, Körber NJ, et al. Quality of life following glaucoma surgery: canaloplasty versus trabeculectomy. Clin Ophthalmol 2014;9:7–16. DOI: 10.2147/OPTH.S72357
  15. Lewis RA, von Wolff K, Tetz M, et al. Canaloplasty: circumferential viscodilation and tensioning of Schlemm's canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: interim clinical study analysis. J Cataract Refract Surg 2007;33(7):1217–1226. DOI: 10.1016/j.jcrs.2007.03.051
  16. Lewis RA, von Wolff K, Tetz M, et al. Canaloplasty: circumferential viscodilation and tensioning of Schlemm canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: two-year interim clinical study results. J Cataract Refract Surg 2009;35(5):814–824. DOI: 10.1016/j.jcrs.2009.01.010
  17. Mansouri K, Shaarawy T. Update on Schlemm's canal based procedures. Middle East Afr J Ophthalmol 2015;22(1):38–44. DOI: 10.4103/0974-9233.148347
  18. Lewis RA, von Wolff K, Tetz M, et al. Canaloplasty: three-year results of circumferential viscodilation and tensioning of Schlemm canal using a microcatheter to treat open-angle glaucoma. J Cataract Refract Surg 2011;37(4):682–690. DOI: 10.1016/j.jcrs.2010.10.055
  19. Ayyala RS, Chaudhry AL, Okogbaa CB, et al. Comparison of surgical outcomes between canaloplasty and trabeculectomy at 12 months’ follow-up. Ophthalmology 2011;118(12):2427–2433. DOI: 10.1016/j.ophtha.2011.05.021
  20. Fujita K, Kitagawa K, Ueta Y, et al. Short-term results of canaloplasty surgery for primary open-angle glaucoma in Japanese patients. Case Rep Ophthalmol 2011;2(1):65–68. DOI: 10.1159/000324808
  21. Gallardo MJ, Supnet RA, Ahmed IIK. Circumferential viscodilation of Schlemm's canal for open-angle glaucoma: ab-interno vs ab-externo canaloplasty with tensioning suture. Clin Ophthalmol 2018;12:2493–2498. DOI: 10.2147/OPTH.S178962
  22. Vastardis I, Fili S, Gatzioufas Z, et al. Ab externo canaloplasty results and efficacy: a retrospective cohort study with a 12-month follow-up. Eye Vis (Lond) 2019;6:9. DOI: 10.1186/s40662-019-0134-5
  23. Matlach J, Freiberg FJ, Leippi S, et al. Comparison of phacotrabeculectomy versus phacocanaloplasty in the treatment of patients with concomitant cataract and glaucoma. BMC Ophthalmol 2013;13:1. DOI: 10.1186/1471-2415-13-1
  24. Arthur SN, Cantor LB, WuDunn D, et al. Efficacy, safety, and survival rates of IOP-lowering effect of phacoemulsification alone or combined with canaloplasty in glaucoma patients. J Glaucoma 2014;23(5):316–320. DOI: 10.1097/IJG.0b013e3182741ca9
  25. Zhang L, Yao Y, Lin Q, et al. Clinical application of the CO2 laser in Ab externo Schlemm's canal surgery. Front Med 2022;9:974056. DOI: 10.3389/fmed.2022.974056
  26. Godfrey DG, Fellman RL, Neelakantan A. Canal surgery in adult glaucomas. Curr Opin Ophthalmol 2009;20(2):116–121. DOI: 10.1097/ICU.0b013e32831eef65
  27. Riva I, Brusini P, Oddone F, et al. Canaloplasty in the treatment of open-angle glaucoma: a review of patient selection and outcomes. Adv Ther 2019;36(1):31–43. DOI: 10.1007/s12325-018-0842-6
  28. Brandão LM, Grieshaber MC. Update on minimally invasive glaucoma surgery (MIGS) and new implants. J Ophthalmol 2013;2013:705915. DOI: 10.1155/2013/705915
  29. Khaimi MA. Canaloplasty: a minimally invasive and maximally effective glaucoma treatment. J Ophthalmol 2015;2015:485065. DOI: 10.1155/2015/485065
  30. Garris WJ, Le C, Zurakowski D, et al. Comparison of surgical outcomes between canaloplasty and trabeculectomy with mitomycin C at 2-year follow-up: a longitudinal cohort study. Indian J Ophthalmol 2018;66(1):66–70. DOI: 10.4103/ijo.IJO_543_17
  31. Gołaszewska K, Konopińska J, Obuchowska I. Evaluation of the efficacy and safety of canaloplasty and iStent bypass implantation in patients with open-angle glaucoma: a review of the literature. J Clin Med 2021;10(21):4881. DOI: 10.3390/jcm10214881
  32. Francis BA, Akil H, Bert BB. Ab interno Schlemm's canal surgery. Develop Ophthalmol 2017;59:127–146. DOI: 10.1159/000458492
  33. Gallardo MJ. 36-month effectiveness of ab-interno canaloplasty standalone versus combined with cataract surgery for the treatment of open-angle glaucoma. Ophthalmol Glaucoma 2022;5(5):476–482. DOI: 10.1016/j.ogla.2022.02.007
  34. Koerber N, Ondrejka S. Four-year efficacy and safety of iTrack ab-interno canaloplasty as a standalone procedure and combined with cataract surgery in open-angle glaucoma. Klin Monbl Augenheilkd 2023;240(12):1394–1404. DOI: 10.1055/a-1737-4149
  35. Khaimi MA. Long-term medication reduction in controlled glaucoma with iTrack ab-interno canaloplasty as a standalone procedure and combined with cataract surgery. Ther Adv Ophthalmol 2021;13:25158414211045751. DOI: 10.1177/25158414211045751
  36. Gallardo MJ, Supnet RA, Ahmed IIK. Viscodilation of Schlemm's canal for the reduction of IOP via an ab-interno approach. Clin Ophthalmol 2018;12:2149–2155. DOI: 10.2147/OPTH.S177597
  37. Gallardo MJ. 24-month efficacy of viscodilation of Schlemm's canal and the distal outflow system with iTrack ab-interno canaloplasty for the treatment of primary open-angle glaucoma. Clin Ophthalmol 2021;15:1591–1599. DOI: 10.2147/OPTH.S272506
  38. Körber N. Ab interno canaloplasty for the treatment of glaucoma: a case series study. Spektrum Augenheilkd 2018;32(6):223–227. DOI: 10.1007/s00717-018-0416-7
  39. Kazerounian S, Zimbelmann M, Lörtscher M, et al. Canaloplasty ab interno (AbiC) - 2-year-results of a novel minimally invasive glaucoma surgery (MIGS) technique. Klin Monbl Augenheilkd 2021;238(10):1113–1119. DOI: 10.1055/a-1250-8431
  40. Körber N. [Canaloplasty ab interno - a minimally invasive alternative]. Klin Monbl Augenheilkd 2017;234(8):991–995. DOI: 10.1055/s-0042-123829
  41. Gillmann K, Aref A, Niegowski LJ, et al. Combined ab interno viscocanaloplasty (ABiC) in open-angle glaucoma: 12-month outcomes. Int Ophthalmol 2021;41(10):3295–3301. DOI: 10.1007/s10792-021-01891-1
  42. Ondrejka S, Körber N. 360° ab-interno Schlemm's canal viscodilation in primary open-angle glaucoma. Clin Ophthalmol 2019;13:1235–1246. DOI: 10.2147/OPTH.S203917
  43. Tracer N, Dickerson JE Jr, Radcliffe NM. Circumferential viscodilation ab interno combined with phacoemulsification for treatment of open-angle glaucoma: 12-month outcomes. Clin Ophthalmol 2020;14:1357–1364. DOI: 10.2147/OPTH.S252965
  44. Hirsch L, Cotliar J, Vold S, et al. Canaloplasty and trabeculotomy ab interno with the OMNI system combined with cataract surgery in open-angle glaucoma: 12-month outcomes from the ROMEO study. J Cataract Refract Surg 2021;47(7):907–915. DOI: 10.1097/j.jcrs.0000000000000552
  45. Williamson BK, Vold SD, Campbell A, et al. Canaloplasty and trabeculotomy with the OMNI system in patients with open-angle glaucoma: two-year results from the ROMEO study. Clin Ophthalmol. 2023;17:1057–1066. DOI: 10.2147/OPTH.S407918
  46. Vold SD, Williamson BK, Hirsch L, et al. Canaloplasty and trabeculotomy with the OMNI system in pseudophakic patients with open-angle glaucoma: the ROMEO study. Ophthalmol Glaucoma 2021;4(2):173–181. DOI: 10.1016/j.ogla.2020.10.001
  47. Gallardo MJ, Pyfer MF, Vold SD, et al. Canaloplasty and trabeculotomy combined with phacoemulsification for glaucoma: 12-month results of the GEMINI study. Clin Ophthalmol 2022;16:1225–1234. DOI: 10.2147/OPTH.S362932
  48. Toneatto G, Zeppieri M, Papa V, et al. 360° ab-interno schlemm's canal viscodilation with OMNI viscosurgical systems for open-angle glaucoma-midterm results. J Clin Med 2022;11(1):259. DOI: 10.3390/jcm11010259
  49. Klabe K, Kaymak H. Standalone trabeculotomy and viscodilation of Schlemm's canal and collector channels in open-angle glaucoma using the OMNI surgical system: 24-month outcomes. Clin Ophthalmol 2021;15:3121–3129. DOI: 10.2147/OPTH.S325394
  50. Grabska-Liberek I, Duda P, Rogowska M, et al. 12-month interim results of a prospective study of patients with mild to moderate open-angle glaucoma undergoing combined viscodilation of Schlemm's canal and collector channels and 360° trabeculotomy as a standalone procedure or combined with cataract surgery. Eur J Ophthalmol 2022;32(1):309–315. DOI: 10.1177/1120672121998234
  51. Murphy Iii JT, Terveen DC, Aminlari AE, et al. ROMEO study group. a multicenter 12-month retrospective evaluation of canaloplasty and trabeculotomy in patients with open-angle glaucoma: the ROMEO 2 study. Clin Ophthalmol 2022;16:3043–3052. DOI: 10.2147/OPTH.S384105
  52. Matlach J, Dhillon C, Hain J, et al. Trabeculectomy versus canaloplasty (TVC study) in the treatment of patients with open-angle glaucoma: a prospective randomized clinical trial. Acta Ophthalmol 2015;93(8):753–761. DOI: 10.1111/aos.12722
  53. Gołaszewska K, Obuchowska I, Konopińska J. Efficacy and safety of ab externo phaco-canaloplasty versus first-generation iStent bypass implantation combined with phacoemulsification in patients with primary open angle glaucoma-early results. Int J Environ Res Public Health 2023;20(2):1365. DOI: 10.3390/ijerph20021365
  54. Gandolfi SA, Ungaro N, Ghirardini S, et al. Comparison of surgical outcomes between canaloplasty and Schlemm's canal scaffold at 24 months’ follow-up. J Ophthalmol 2016;2016:3410469. DOI: 10.1155/2016/3410469
  55. Dickinson A, Leidy L, Nusair O, et al. Short-term outcomes of hydrus microstent with and without additional canaloplasty during cataract surgery. J Glaucoma 2023;32(9):769–776. DOI: 10.1097/IJG.0000000000002245
  56. Creagmile J, Kim WI, Scouarnec C. Hydrus microstent implantation with OMNI surgical system ab interno canaloplasty for the management of open-angle glaucoma in phakic patients refractory to medical therapy. Am J Ophthalmol Case Rep 2022;29:101749. DOI: 10.1016/j.ajoc.2022.101749
  57. Patel S, Reiss G. Long-term clinical and safety outcomes of canaloplasty performed across all grades of glaucoma severity. J Ophthalmol 2023;2023:5625990. DOI: 10.1155/2023/5625990
  58. Yadgarov A, Dentice K, Aljabi Q. Real-world outcomes of canaloplasty and trabeculotomy combined with cataract surgery in eyes with all stages of open-angle glaucoma. Clin Ophthalmol 2023;17:2609–2617. DOI: 10.2147/OPTH.S422132
  59. Riaz KM, Gill MS, Murphy DA, et al. Surgical management of intraocular pressure with ab interno canaloplasty in postkeratoplasty patients: 12-month results. Cornea 2023;42(1):52–59. DOI: 10.1097/ICO.0000000000003009
  60. Terveen DC, Sarkisian SR Jr, Vold SD, et al. Canaloplasty and trabeculotomy with the OMNI® surgical system in OAG with prior trabecular microbypass stenting. Int Ophthalmol 2023;43(5):1647–1656. DOI: 10.1007/s10792-022-02553-6
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.